Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

Autor:	E Hsu, John C. Byrd, S Chang, Jennifer R. Brown, Marco Montillo, Florence Cymbalista, Devinder Gill, Susan O'Brien, Stephen P. Mulligan, C Plascencia, Danelle F. James, Peter Hillmen, Claire Dearden, Alessandra Tedeschi, Jaqueline C. Barrientos, Richard R. Furman
Rok vydání:	2017
Předmět:	medicine.medical_specialty Chronic lymphocytic leukemia Antineoplastic Agents Antibodies Monoclonal Humanized 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Piperidines hemic and lymphatic diseases Internal medicine medicine Humans Letter to the Editor Randomized Controlled Trials as Topic Retrospective Studies Purpura Thrombocytopenic Idiopathic Hematology business.industry Adenine Translational biology Antibodies Monoclonal medicine.disease Leukemia Lymphocytic Chronic B-Cell Lymphoma Leukemia Pyrimidines Treatment Outcome Oncology chemistry Clinical Trials Phase III as Topic 030220 oncology & carcinogenesis Ibrutinib Immunology Pyrazoles Anemia Hemolytic Autoimmune Previously treated business 030215 immunology
Zdroj:	Blood Cancer Journal
ISSN:	2044-5385
Popis:	Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417394c78b4f4b9d8aed85ac89a3bda2 https://pubmed.ncbi.nlm.nih.gov/28157216 Zobrazit plný text záznamu